Gefitinib and performance status decreased Patient Reports February 12, 2012

Gefitinib Side Effects Report #4633257-2
Gefitinib side effect was reported by a Consumer or non-health professional from on Mar 30, 2005. Male patient, 38 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: dyspnoea, performance status decreased, pneumonia , tumour necrosis. Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with IBUHEXAL, LISIGAMMA, RIFUN, TEPILTA. Patient was hospitalized. Patient recovered.

Gefitinib Side Effects Report #4553303-4
Gefitinib side effect was reported by a Consumer or non-health professional from on Jan 03, 2005. Male patient, 37 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: c-reactive protein increased, cough, lung infiltration, performance status decreased, pyrexia, weight decreased, white blood cell count increased. Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with IBUHEXAL, LISIGAMMA, RIFUN, TEPILTA. Patient was hospitalized. Patient recovered.

Gefitinib Side Effects Report #4557271-0
Gefitinib side effect was reported by a Consumer or non-health professional from on Jan 10, 2005. Male patient, 37 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: performance status decreased, pneumonia bacterial, weight decreased, white blood cell count decreased. Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with IBUHEXAL, LISIGAMMA, RIFUN, TEPILTA. Patient was hospitalized. Patient recovered.

Gefitinib Side Effects Report #4568279-3
Gefitinib side effect was reported by a Consumer or non-health professional from on Jan 21, 2005. Male patient, 37 years of age, weighting 156.5 lb, was diagnosed with non-small cell lung cancer and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: lung infiltration, performance status decreased, pneumonia bacterial, pneumonitis, weight decreased. Gefitinib dosage: 250 MG DAILY PO. During the same period patient was treated with IBUHEXAL, LISIGAMMA, RIFUN, TEPILTA. Patient was hospitalized. Patient recovered.


Gefitinib Side Effects Report #4697272-5
Gefitinib side effect was reported by a Physician from on Mar 30, 2005. Male patient, weighting 167.6 lb, was diagnosed with non-small cell lung cancer, pain , hypertension, gastritis and was treated with Gefitinib. After drug was administered, patient experienced the following side effects: dyspnoea exacerbated, performance status decreased, pneumonia . Gefitinib dosage: unknown. During the same period patient was treated with IBUHEXAL, LISIGAMMA, RIFUN, TEPILTA. Patient was hospitalized. Patient recovered.